Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-131697
Filing Date
2025-05-30
Accepted
2025-05-30 10:51:34
Documents
7
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 6-K d947351d6k.htm 6-K 9968
2 EX-99.1 d947351dex991.htm EX-99.1 13432
3 EX-99.2 d947351dex992.htm EX-99.2 22000
4 EX-99.3 d947351dex993.htm EX-99.3 41014
5 GRAPHIC g947351g0530164328702.jpg GRAPHIC 2580
6 GRAPHIC g947351g0530164329315.jpg GRAPHIC 1148
7 GRAPHIC g947351g0530164748024.jpg GRAPHIC 2580
  Complete submission text file 0001193125-25-131697.txt   96786
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251007840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)